Methylene Blue Research: Studies, Trials & Evidence (2026)
Over 150 peer-reviewed studies, 27 PMC-linked sources, and 12+ clinical trials document methylene blue's effects on cognition, neurodegeneration, and longevity as of 2026. Every claim below is backed by PubMed Central full-text.
Explore Methylene Blue Research Topics
Brain Health & Cognitive Function
fMRI evidence for improved attention and memory. Rodriguez et al. (2016) demonstrated enhanced sustained attention in a double-blind RCT.
Alzheimer's Disease Research
Editorial overview of Wischik's tau aggregation inhibition research and TauRx LMTM clinical trials. Educational content only.
Clinical Trials Database
Structured database of methylene blue clinical trials. Searchable by condition, phase, and status from ClinicalTrials.gov.
Longevity & Anti-Aging
Epigenetic age research, mitochondrial theory of aging, and TruDiagnostic biomarker compatibility for measuring biological age changes.
Each research domain has its own deep-dive page. Start with the brain health research for fMRI-backed cognitive findings, explore the clinical trial database for 12 registered studies across 8 conditions, or review longevity and epigenetic age research on biological age reversal markers. For a broader overview of methylene blue mechanisms and ATP synthesis, see the clinical evidence overview.
Rodriguez et al. (2016) — fMRI Evidence for Cognitive Enhancement
The most rigorous human trial on methylene blue cognitive effects. A double-blind, placebo-controlled RCT (n=26) using functional MRI to measure brain activity changes. Results showed significantly improved sustained attention and memory retrieval with acute low-dose methylene blue administration.
Research Methodology
All studies cited in this research hub are indexed in PubMed Central (PMC) with full-text access. We prioritize randomized controlled trials (RCTs), systematic reviews, and meta-analyses. Preclinical studies are included where human data is limited, with clear labeling. Evidence quality is graded using standard research hierarchy: RCT > Cohort > Case-Control > Case Series > Preclinical. Most human data is preclinical or small-n; only Rodriguez 2016 is a double-blind fMRI RCT.
For MB Ultra buyers: this means protocol decisions should weight the one RCT-grade signal (Rodriguez 2016) and the preclinical mechanism body differently — which is why the 90-day biomarker-tracking protocol exists to produce per-user data rather than rely on small-n studies alone.
Apply the research
Disclaimer: This research hub is for educational purposes only. Methylene Blue Ultra is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease. The research discussed represents academic findings and does not constitute medical advice. Consult a healthcare provider before starting any supplement regimen.
Free: The Biohacker's 90-Day MB Protocol
Science-backed dosing schedule + stacking guide
- 3-phase titration protocol (weeks 1-12)
- Weight-based dosing tables
- Synergistic stacking protocols
- Biomarker tracking checklist
No spam. Unsubscribe anytime.